Phase II trial of LUM 001 in adults with primary sclerosing cholangitis (PSC)

Trial Profile

Phase II trial of LUM 001 in adults with primary sclerosing cholangitis (PSC)

Planning
Phase of Trial: Phase II

Latest Information Update: 04 Oct 2013

At a glance

  • Drugs Lopixibat chloride (Primary)
  • Indications Primary sclerosing cholangitis
  • Focus Therapeutic Use
  • Sponsors Lumena Pharmaceuticals
  • Most Recent Events

    • 04 Oct 2013 New trial record
    • 26 Sep 2013 This trial is expected to begin later in 2013, according to a Lumena Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top